Natalizumab versus glatimer acetate in relapsing-remitting multiple sclerosis: a network meta-analysis
Источник:
Value in Health Volume 21, Supplement 3, October 2018, Page S331
Авторы:
M. Sultanov1
A. Almadiyeva2
K. Absattarova2
Y. Semenova3
1) Nazarbayev University, Astana, Kazakhstan
2) Kazakh Agency for Health Technology Assessment, Astana, Kazakhstan
3) Semey State Medical University, Semey, Kazakhstan